Cancer Research Institute - Technology Impact Award | Research Funding

Thumbnail

Event details

Date 01.12.2022  
Category Call for proposal
Aim: The Cancer Research Institute Technology Impact Award aims to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Duration:      24 months

Funding:       $200’000

Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Joint submissions from collaborators will also be considered. (The collaborators will share the award.) Each collaborator must meet the eligibility criteria.

How to Apply: The process for applying for a Tech Impact Grant consists of two parts: a Letter of Intent, and, if invited, a Full Application. Letters of intent and associated supporting documents must be submitted electronically through a special submission portal.

Deadline, Letter of Intent:            15 November 2022
Deadline, Full Application:         15 March 2023 (by invitation only)

Further information
  • More information about the program is available here.
  • The application portal can be found here.
  • For any other questions, please contact the Research Office.

 

Practical information

  • General public
  • Free

Contact

Event broadcasted in

Share